Research Article

5-Lipoxygenase Deficiency Impairs Innate and Adaptive Immune Responses during Fungal Infection

  • Adriana Secatto,

    Affiliation: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil

  • Lilian Cataldi Rodrigues,

    Affiliation: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil

  • Carlos Henrique Serezani,

    Affiliation: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of America

  • Simone Gusmão Ramos,

    Affiliation: Departamento de Patologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil

  • Marcelo Dias-Baruffi,

    Affiliation: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil

  • Lúcia Helena Faccioli,

    Affiliation: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil

  • Alexandra I. Medeiros mail

    Affiliation: Departamento de Ciências Biológicas, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Araraquara, São Paulo, Brazil

  • Published: March 20, 2012
  • DOI: 10.1371/journal.pone.0031701


5-lipoxygenase-derived products have been implicated in both the inhibition and promotion of chronic infection. Here, we sought to investigate the roles of endogenous 5-lipoxygenase products and exogenous leukotrienes during Histoplasma capsulatum infection in vivo and in vitro. 5-LO deficiency led to increased lung CFU, decreased nitric oxide production and a deficient primary immune response during active fungal infection. Moreover, H. capsulatum-infected 5-LO−/− mice showed an intense influx of neutrophils and an impaired ability to generate and recruit effector T cells to the lung. The fungal susceptibility of 5-LO−/− mice correlated with a lower rate of macrophage ingestion of IgG-H. capsulatum relative to WT macrophages. Conversely, exogenous LTB4 and LTC4 restored macrophage phagocytosis in 5-LO deficient mice. Our results demonstrate that leukotrienes are required to control chronic fungal infection by amplifying both the innate and adaptive immune response during histoplasmosis.


Histoplasma capsulatum is a dimorphic, facultative, intracellular fungal pathogen ingested by resident cells such as alveolar macrophages and dendritic cells and by neutrophils when these inflammatory cells are recruited to the site of infection. The immune response against H. capsulatum is mediated by phagocytes, neutrophils, and CD4+ and CD8+ T cells [1]. The clearance of the fungus is associated with Th1-related cytokines, including IL-12, IFN-γ, TNF-α, and GM-CSF, which are essential for the development of a protective immune response in H. capsulatum-infected mice [2], [3], [4]. Fungal clearance is also associated with an overproduction of lipid mediators, such as leukotrienes (LTs), by phagocytes [5]. LTs are bioactive lipids derived from the 5-lipoxygenase (5-LO) pathway of arachidonic acid (AA) metabolism. The 5-LO-activating protein (FLAP) activates 5-LO that then oxygenates AA to form LTA4 [6]. This intermediate can be hydrolized to form LTB4 by LTA4 hydrolase or LTC4 synthase, which catalyzes the conjugation with glutathione to form the LTC4 that will be formed into LTD4 and LTE4, collectively known as cysteinyl LTs (CysLTs) [7]. 5-LO metabolites are known for their ability to function as neutrophil chemoattractants (LTB4) and for their effects on smooth muscle contraction during asthma (CysLTs). Currently, the relative roles of LTs in amplifying the innate and adaptive immune responses are not well understood. While it's been shown that endogenous and exogenous LTs enhance macrophage antimicrobial effector function and secretion of pro-inflammatory molecules [5], [8], [9], [10], other 5-LO derived products, such as lipoxins, may limit Mycobacterium tuberculosis [11] and Trypanosoma cruzi [12] infection. Thus, the specific role of 5-LO products in modulating chronic fungal infection remains to be fully understood. Among their many biological functions, LTs stimulate leukocyte migration and activation [13], microbial phagocytosis and killing [14], [15] and the chemotactic activity for in vitro-activated effector CD4+ and CD8+ T cells [16], [17] and γδ T lymphocytes [18]. Moreover, numerous in vitro and in vivo models have revealed a protective role for endogenous LTs, particularly during bacterial peritonitis and tuberculosis, parasitic and HIV infection [19]. We have recently demonstrated an important role for LTs in the primary and secondary immune responses against H. capsulatum [5], [20]. 5-LO deficiency impairs both the recruitment and activation of memory T cells following immunization against H. capsulatum [20]. Moreover, we have previously shown that pharmacological inhibition of LTs hinders host defense mechanisms during H. capsulatum infection. However, due to the off-target effects of LT inhibitors, which are associated with the partial inhibition of LTs, the precise role of 5-LO metabolites still remains to be determined. Here, by employing a genetic approach, 5-LO deficient mice (5-LO−/−) were used to demonstrate the role of endogenous LTs in histoplasmosis in vivo and in vitro. We demonstrate that LTs play an important role in host defense against H. capsulatum through the modulation of nitric oxide (NO) production, phagocytosis and effector cell recruitment.

Results and Discussion

5-LO deficiency impairs H. capsulatum clearance and animal survival

To determine if LTs are indeed required for host defense during H. capsulatum infection, we initially sought to investigate whether LTs are produced in the lungs of WT sv129-infected animals. Our results show that H. capsulatum infection induced LTB4 and CysLTs production at 7 and 14 days after infection when compared to uninfected mice (Figure 1). Moreover, we observed that greater amounts of LTB4 are produced relative to CysLTs during fungal infection. We then speculated whether the genetic deletion of the LT-generating enzyme would affect both survival and fungal load in murine models. Figure 2A shows that during the 30 days of the infection, 5-LO−/− mice exhibited 100% mortality by day 20 whereas 100% of WT mice survived the infection. Next, we attempted to investigate if the increased mortality was due to higher fungal numbers in the 5-LO deficient lung. We observed that the fungal burden of 5-LO−/− mice was significantly higher than WT mice at day 7 and was more pronounced at 14 days post-infection at the site of local infection (lung) and in the spleen (Figure 2B and 2C). Our data show that 5-LO metabolites are key mediators involved in the control of H. capsulatum infection by inhibiting fungal dissemination to other organs.


Figure 1. LTB4 and CysLTs production in lung tissue.

Enzyme immunoassay quantification of LTB4 and CysLTs concentrations in lungs from mice that had received either an i.t. PBS injection (uninfected) or an i.t. infection with H. capsulatum. Data are presented as the mean ± SEM and are representative of one of two independent experiments (n = 6). *, p<0.05 vs. PBS.


Figure 2. Effect of 5-LO deficiency on survival, fungal burden and NO2 production.

(A) 5-LO−/− and WT mice were infected i.t. with 3×106 yeast H. capsulatum and survival was monitored for 30 days (n = 6). CFU numbers in lungs (B) and spleen (C) were evaluated at 7 and 14 days post H. capsulatum infection. (D) NO2 levels were quantified in the supernatant of lung homogenates at different time points using a Griess reaction. Data are expressed as the mean ± SEM from one experiment representative of a total of two experiments (n = 6). *, p<0.05 vs. PBS; #, p<0.05 vs. WT.


LT-enhanced fungicidal activity in the lung is associated with nitric oxide (NO) generation

NO is a key microbicidal molecule involved in the control of H. capsulatum infection [21]. In addition, previous studies have shown that LTs enhance NO production in macrophages infected with protozoan parasites or macrophages stimulated with TLR agonists [22], [23], [24]. We next assessed whether increased susceptibility of 5-LO−/− mice could be associated with lung NO production during fungal infection. Indeed, while H. capsulatum infection increased NO production in the lungs of WT mice at 7 days post-infection, 5-LO deficiency decreased NO production by ~30% at day 7 and ~50% at day 14 in the lungs of infected 5-LO−/− mice as compared to infected WT mice (Figure 2D).

The low levels of NO in 5-LO−/− mice may be related to a deficiency in the production of 5-LO metabolites, such as LTs and lipoxins. The inhibition of NO synthesis by LT inhibitors or receptor antagonists has been demonstrated previously in other experimental models, such as T. cruzi [24], M. tuberculosis [8], and VSV encephalitis infection [10]. The predominance of neutrophils in the lungs of 5-LO−/− infected mice suggests that 5-LO products may interfere either directly or indirectly with the synthesis of NO by neutrophils. In addition, the low levels of NO in the lungs of infected 5-LO−/− mice could be explained by the predominance of neutrophils over macrophages. Macrophages are able to produce higher amounts of NO in the presence of inflammatory stimuli than neutrophils [25]. Therefore, our data suggest that low levels of NO, either by the predominance of neutrophils or through the modulation of NO metabolites by 5-LO products, could help explain the increased susceptibility to infection of 5-LO−/− animals.

LT-deficiency exacerbates the inflammatory response in the lung

To understand the increased fungal susceptibility of 5-LO−/− mice, we examined the lungs using histopathological analysis. We observed an intense amount of inflammatory infiltrates in the lungs from WT infected-mice at days 7 and 14 post-infection, with a higher recruitment of neutrophils and mononuclear cells than the PBS-treated group (Figure 3A and B). Alternatively, lung tissue from 5-LO−/− mice presented with an intense leukocyte infiltration with a predominance of neutrophils at days 7 and 14 post-infection as compared with WT mice (Figure 3A and B). Moreover, the strong influx of neutrophils in 5-LO−/− mice was associated with high levels of TNF-α (Figure 3C). The intense neutrophil recruitment observed in 5-LO−/− mice infected with H. capsulatum corroborates our previous findings [5]. The higher levels of TNF-α observed in 5-LO deficient mice and the exacerbation of neutrophil recruitment could be explained by the opposing effects of leukotrienes and lipoxins. While LTB4 enhances neutrophil recruitment and protects neutrophils from apoptosis, lipoxins enhance neutrophil efferocytosis by macrophages [26], [27]. Thus, the higher neutrophil recruitment to the lungs of 5-LO−/− mice may be due to a lack of apoptotic cell clearance by macrophages due to the presence of lipoxin and an increase in apoptotic cells in the absence of LTB4. Moreover, the exacerbated neutrophil recruitment to the lung of 5-LO deficient infected mice may be associated with decreased levels of NO due to the modulation of chemotactic mediators other than LTs. Peritoneal macrophages from animals deficient in iNOS produce increased amounts of MCP-1 by promoting increased expression of CC chemokine receptors, which favors the efficient recruitment of neutrophils [28].


Figure 3. 5-LO deficiency increases the inflammatory response in the lung.

Representative lung sections from WT and 5-LO−/− mice infected with H. capsulatum (A). Hematoxylin-eosin staining for leukocytes (magnifications ×100) and GMS staining for yeast cells (black arrow) (magnifications ×400). (B) Neutrophils recruitment from lung parenchyma (C) TNF-α production from homogenized lungs. Cells and cytokines were obtained as described in the Material and Methods section from mice after i.t. injection of PBS or i.t. infection with H. capsulatum. Cells were enumerated and identified after Rosenfeld staining, and TNF-α levels were determined by ELISA. Data are expressed as the mean ± SEM from one experiment representative of a total of two experiments (n = 6). *, p<0.05 vs. PBS; #, p<0.05 vs. WT.


Even though neutrophils are important for the control of H. capsulatum infection, this cell type is known to exhibit more intense fungistatic versus fungicidal activity [29], [30], [31]. Based on this observation, we suggest that the inability of neutrophils to perform fungicidal or fungistatic functions may be impaired due to the absence of several factors, including LT synthesis. Mancuso et al. [32] showed that neutrophil phagocytosis of Klebsiella pneumonia is augmented by LTB4 and this mediator also participates in antimicrobial host defense [33]. However, other groups have shown that M. tuberculosis-infected 5-LO−/− mice exhibit decreased neutrophil recruitment to the site of infection, decreased NOS2 mRNA levels and no modulation of TNF-α production [11]. The explanation for such contradictory effects may be related to the levels of lipoxin and leukotrienes induced by H. capsulatum and M. tuberculosis infection. The predominance or reduction of lipoxin and leukotrienes during the course of infection and the cross-talk between these mediators may explain contradictory results in both models. Whether lipoxins are important for H. capsulatum infection remains to be determined.

Endogenous 5-LO metabolites increase phagocytosis of H. capsulatum

The effect of LTs on the enhancement of fungal host defense could be reflected by a diminished phagocytic capability of LT-deficient macrophages. It is known that LTs enhance phagocytosis of both IgG-opsonized bacteria and nonopsonized targets [34], [35]. Here, we determined the ability of 5-LO−/− and WT peritoneal macrophages (PMs) to phagocytose H. capsulatum. WT macrophages exhibited higher rates of phagocytosis in IgG-opsonized H. capsulatum than for non-opsonized yeast. 5-LO deficient cells exhibited less phagocytosis of both opsonized and non-opsonized yeast when compared to WT macrophages (Figure 4A). These results demonstrated that endogenously produced 5-LO products are required for macrophage phagocytosis of H. capsulatum yeast. Bailie et al. [9] demonstrated that the increased susceptibility of 5-LO deficient mice during K. pneumoniae infection is associated with a deficiency in the phagocytic and bactericidal capacity of alveolar macrophages. Similarly, Morato-marques [35] showed that both LTB4 and CysLTs enhance both phagocytosis and killing of C. albicans by alveolar macrophages. In addition, exogenous LTs were able to restore the phagocytic ability of 5-LO−/− alveolar macrophages infected with K. pneumoniae [14], [15]. Because our current results did not distinguish among the 5-LO products, we performed “add-back” experiments in which we added LTB4 or LTC4 to 5-LO−/− macrophages and then measured phagocytosis. Pretreatment with LTB4 and LTC4 restored IgG-opsonized H. capsulatum phagocytosis by PMs from 5-LO−/− mice in a dose-dependent manner (Figure 4B and 4C). We did not investigate whether LTs enhance H. capsulatum killing; however, we have previously observed that both LTB4 and CysLTs enhance the response to different pathogens. We demonstrated that LTB4 enhances the defense against K. pneumoniae and C. albicans in a manner dependent on ROI secretion; depletion of L. amazonensis is dependent on RNI generation by LTs. Because an effective immune response against H. capsulatum is mainly dependent on RNI production [36], we speculated that LTB4 could enhance NO secretion, which would further deplete H. capsulatum. The decreased NO synthesis observed in the Figure 2D reinforces our hypothesis. Resident macrophages are strategically distributed throughout various organs to maintain immunosurveillance through the phagocytosis, killing, and secretion of regulatory molecules, such as cytokines and lipid mediators. Since H. capsulatum is a facultative intracellular pathogen, our data may suggest that the inhibition of phagocytic ability may favor the proliferation of H. capsulatum outside of macrophages and could explain the increased CFU we observed in the lungs and spleens of 5-LO−/− mice.


Figure 4. 5-LO deficiency affects the ability of macrophages to phagocytose H. capsulatum.

(A) PMs from WT and 5-LO−/− mice were incubated for 1 h with a yeast:macrophage ratio of 1:5 in the absence or presence of IgG. PMs were pretreated with LTB4 (B) and LTC4 (C) for 5 min before the addition of opsonized H. capsulatum. Phagocytosis was calculated as described in the Material and Methods section and was expressed as a percentage of the control. Data are expressed as the mean ± SEM from one experiment representative of a total of three experiments (n = 6). *, p<0.05 vs. control; #, p<0.05 vs. WT cells; & p<0.05 vs. 5-LO−/− cells.


Our results show that among all 5-LO products produced during fungal infection, LTB4 and LTC4 improve the phagocytosis of opsonized H. capsulatum by peritoneal macrophages.

Effect of 5-LO deficiency in recruitment of effector T cells

Previous studies have shown that LTs are important chemotactic factors for CD4+ [16] and CD8+ [17] T cells and that this recruitment depends on the expression of the BLT1 receptor. Next, we assessed whether H. capsulatum-infected 5-LO−/− mice demonstrated defective leukocyte recruitment to the site of infection. Other than the importance of innate effector mechanisms that control fungal infection, a protective immune response against H. capsulatum also depends on the activation of antigen-specific CD4+ and CD8+ T cells [1]. We next explored the role of endogenous LTs in the recruitment of CD4+ and CD8+ effector T cells during H. capsulatum infection. The recruited population of effector CD4+ and CD8+ T cells was CD44high and CD62low, and the number of CD4+ and CD8+ T cells increased progressively during infection in WT animals when compared with the PBS-treated group. In contrast, 5-LO deficiency blunted T cell recruitment to the lungs of infected 5-LO−/− mice (Figure 5A and 5B).


Figure 5. Deficiency of 5-LO impairs T cell recruitment to the lung.

Cells were obtained as described in the Material and Methods section from mice after i.t. injection of PBS or i.t. infection with H. capsulatum. The lymphocyte population was gated for forward/side scatters and analyzed the percentage of T cells expressing a phenotype effector (CD44high/CD62low). (A) CD4+ T cells, CD8+ T cells (B) and T cell proliferation(C). Data are presented as the mean ± the SEM from three experiments. *, WT and 5-LO−/− vs. PBS; #, WT vs. 5-LO−/−. p<0.05.


Islam et al. [37] also showed that LTB4-BLT1 is a chemoattractant for CD4+ and CD8+ effector and memory T cells. Furthermore, we have shown that recruitment or activation of memory T cells (CD4+ and CD8+) during the secondary immune response against H. capsulatum was suppressed and was associated with an increased susceptibility for 5-LO deficient mice [20]. To determine whether the absence of effector T cells was due to decreased recruitment or generation of these cells, we performed proliferation assays using CFSE dilution of spleen cells from uninfected WT and 5-LO−/− mice (PBS) and H. capsulatum-infected mice. As shown in Figure 5C, spleen cells from WT and 5-LO−/− PBS and H. capsulatum-infected mice proliferate in vitro with α-CD3 and α-CD28 stimulation (polyclonal). Interestingly, only spleen cells from WT infected mice proliferated after stimulation with cell-free antigens (CFAgs, antigen-specific stimulation). Taken together, our results suggest that the increased mortality and CFU number in 5-LO−/− mice may be associated with a deficiency in the activation and proliferation of antigen-specific T cells in the draining lymph node and the recruitment of these cells to the site of infection. The mechanisms underlying the role of LTs in T cell proliferation remain to be determined; however, some possibilities include the activation of Src and Syk kinases, which are known to be important for T cell proliferation and are also activated by LTB4 [38].

In summary, we demonstrate that inhibition of the 5-LO enzyme resulted in enhanced susceptibility to pulmonary fungal infection, which is associated with lung fungal persistence, decreased NO production, decreased phagocytic capacity and impaired proliferation and/or activation of effector T cells. These findings indicate that LTs are essential mediators that enhance the innate and adaptive immune response in the context of chronic infections such as histoplasmosis.

Materials and Methods


5-LO deficient or knockout (5 LO−/−) (129-Alox5tmlfun) mice and strain-matched wild-type (WT) sv129 mice (6–8 weeks old) were obtained from The Jackson Laboratory (Bar Harbor, ME, USA) and were bred in the Faculdade de Ciências Farmacêuticas de Ribeirão Preto (Universidade de São Paulo, Brazil). All experiments were approved and conducted in accordance with the guidelines of the Animal Care Committee of the University. Infected animals were kept in biohazard facilities and were housed in cages within a laminar flow safety enclosure under standard conditions.

Preparation of H. capsulatum and infection of mice

The H. capsulatum strain used in this study was isolated from a human pulmonary clinical isolate at the Hospital das Clínicas from Faculdade de Medicina de Ribeirão Preto (Universidade de São Paulo, Brazil). Live mycelia were obtained by fungal culture at 25°C on Sabouraud dextrose agar (Difco, Detroit, MI, USA) for 2 months, and conidia morphology was observed. Later, mycelia were grown in BHI blood agar at 37°C for 7–15 days to convert them to yeast form and morphology was also confirmed.

Yeast cells were used when their viability was ≥90% based on fluorescein diacetate and ethidium bromide. The infection was performed as described previously [20]. Briefly, mice were anesthetized with tribromoethanol 2.5%, restrained on a small board and infected by the intratracheal route. Animals received either 100 µl phosphate buffered saline (PBS) or 3×106 viable H. capsulatum yeast in 100 µl PBS (sublethal inoculum of H. capsulatum).

Quantitation of fungal load in the spleen and lungs

Recovery of H. capsulatum was performed as previously described by Sá-Nunes et al. [39]. Three serial dilution was made and 0.2 ml of the dilution was plated on a BHI-agar-blood slant. The fungal burden was counted after incubation at 37°C for 21 days. The results are expressed as colony forming units (CFU) per lung and spleen.

Quantitation of NO

NO production was determined by measuring the amount of nitrite (NO2) in lung homogenates, obtained as described above, using the Greiss reaction as previously described [5].

Measurement of LTs and cytokine

Lungs were removed on days 7 and 14 post-infection to measure LTB4, CysLTs and TNF-α. Briefly, tissue was homogenized (Mixer Homogenizer, Labortechnik, Germany) in 2 ml of RPMI1640, centrifuged and stored at −70°C until assayed. A specific enzyme immunoassay was used to quantify LTB4 and CysLTs (LTC4/D4/E4, Cayman Chemical, Ann Arbor, Mich.) according to the manufacturer's instructions [20]. Commercially available ELISAs were used to measure TNF-α (R&D Systems, Minneapolis, MN). The sensitivity of the assay was <10 pg/ml.

Histopathologic analysis

Lungs were removed on days 7 and 14 post-infection, and tissues were fixed in 10% formalin, embedded in paraffin, cut into four to five µm sections and stained with haematoxylin and eosin (HE) and Grocott's methanemine silver (GMS). Analysis of these sections was performed with a video camera (Leica Microsystems Ltd., Heebrugg, Switzerland) applied to a Leica microscope DMR (Leica, Microsystems GmbH, Wetzlar, Germany) that was attached to a computer. Images were processed by Leica QWin software (Leica Microsystems Image Solutions, Cambridge, UK).

Peritoneal macrophages (PMs) isolation and culture

PMs were obtained from control 5-LO−/− and WT mice by washing peritoneal cavities with 5 ml of ice-cold phosphate buffered saline (PBS). The cells were centrifuged (160×g, 10 min, 4°C), resuspended in RPMI 1640 medium, and were adjusted to 2×106 cells/ml. The percentage of macrophages was determined microscopically using a modified Rosenfeld stain, where a typical experiment yielded ~95% macrophages. Cells were cultured overnight in RPMI containing 10% fetal bovine serum and were washed twice the next day with warm free serum medium so that non-adherent cells could be removed.

Fungal phagocytosis assays

Phagocytosis assays were assessed using an adapted protocol that was previously described [40]. Briefly, H. capsulatum yeast was opsonized with 10% heat-inactivated specific immune serum (IgG) for 40 min at 37°C. The serum containing specific IgG without complement was prepared by heating to 65°C for 30 minutes in water bath. After opsonization, yeast cells were washed and labeled with FITC (AMRESCO) for 1 h at 37°C. IgG-opsonized FITC-labeled H. capsulatum was further diluted in RPMI incubated with PMs at a ratio of 1:5 (yeast cell: macrophage). After a 1 h incubation in the dark (37°C, 5% CO2), uningested yeasts cell were washed with phosphate buffered saline (PBS), and residual extracellular FITC was quenched with trypan blue (250 mg/ml; Molecular Probes) for 1 min. Fluorescence was determined with a microplate fluorometer (485ex/535em,SPECTRAFluor Plus; Tecan, Research Triangle Park, NC). In some experiments, cells were pretreated for 5 min with LTB4 or LTC4 (Cayman Chemical, Ann Arbor, Mich.) diluted in RPMI before the addition of IgG-opsonized FITC labeled H. capsulatum. The results are expressed as a percentage of the control.

Spleen cells isolation and proliferation assay

Spleens from infected mice (7 days post-infection) and age-matched uninfected control mice were aseptically removed and minced, and the released cells were washed three times in RPMI 1640 (Gibco BRL, Grand Island, USA). Cells were resuspended at 5×106 cells/ml in RPMI supplemented with 10% fetal bovine serum (Gibco BRL), penicillin (100 U/ml, Gibco BRL) and streptomycin (100 µg/ml, Gibco BRL) and were dispensed into 96-well flat- bottom microtiter plates in 0.1 ml. For polyclonal stimulation, α-CD3, α-CD28 (2 µg/ml, Sigma Chemical Co., St. Louis, USA) and specific stimulation, cell-free antigens from H. capsulatum (CFAgs) (50 µg/ml) [39] were added to wells (0.1 ml) in triplicate and cultured for 72 h at 37°C. Splenic cell proliferation was measured by dilution of intracellular CFSE staining as detected by flow cytometry (FACSort™ - BD Bioscience).

Leukocytes isolated from lung parenchyma

Approximately 7 and 14 days following infection, the lung was removed and total cells were obtained by enzymatic digestion as described previously [41]. Leukocyte numbers and differential counts for neutrophils were obtained as described previously [42].

Flow cytometric analysis

Lung leukocytes were adjusted to a concentration of 5×105 cells/100 µL, and FcγRs were blocked by the addition of unlabeled anti-CD16/32. Leukocytes were stained with anti-CD4 mAb (PerCP- Cy 5.5), -CD8 mAb(PerCP Cy.5.5), -CD44 mAb (FITC) and -CD62 L (PE) mAb murine specific and isotype controls for 30 min at 4°C (BD Pharmingen) as previously described [20]. The results were calculated by determining the percentage of total CD4+ or CD8+ T cells with an effector phenotype (CD4+CD44 highCD62 Llow/neg or CD8+CD44 highCD62 Llow/neg). T cell immunophenotyping was performed using FACSort (BD Biosciences) and CellQuest software, and T cell proliferation was analyzed using FACSCanto (BD Biosciences) and FACSDiva software.

Statistical analysis

The data are presented as the mean ± SEM. Comparisons were performed using an ANOVA followed by the Bonferroni test by the Prism 4.0 statistical program (GraphPad Software, San Diego,CA). Differences in survival were analyzed by the log rank test. Values of p<0.05 were considered statistically significant.


The authors would like to acknowledge Fabiana Rosseto Morais, Carlos Artério Sorgi and Eliane Floriano for technical assistance.

Author Contributions

Conceived and designed the experiments: AS AIM LHF. Performed the experiments: AS LCR AIM. Analyzed the data: AS LHF CHS AIM. Contributed reagents/materials/analysis tools: LHF AIM SGR. Wrote the paper: AS CHS MDB AIM.


  1. 1. Deepe GS Jr (2000) Immune response to early and late Histoplasma capsulatum infections. Curr Opin Microbiol 3: 359–362.
  2. 2. Zhou P, Sieve MC, Bennett J, Kwon-Chung KJ, Tewari RP, et al. (1995) IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J Immunol 155: 785–795.
  3. 3. Allendoerfer R, Deepe GS Jr (2000) Regulation of infection with Histoplasma capsulatum by TNFR1 and -2. J Immunol 165: 2657–2664.
  4. 4. Deepe GS Jr, Gibbons R, Woodward E (1999) Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum. J Immunol 163: 4985–4993.
  5. 5. Medeiros AI, Sa-Nunes A, Soares EG, Peres CM, Silva CL, et al. (2004) Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis. Infect Immun 72: 1637–1644.
  6. 6. Samuelsson B (1983) Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220: 568–575.
  7. 7. Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871–1875.
  8. 8. Peres CM, de Paula L, Medeiros AI, Sorgi CA, Soares EG, et al. (2007) Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis. Microbes Infect 9: 483–489.
  9. 9. Bailie MB, Standiford TJ, Laichalk LL, Coffey MJ, Strieter R, et al. (1996) Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol 157: 5221–5224.
  10. 10. Chen N, Restivo A, Reiss CS (2001) Leukotrienes play protective roles early during experimental VSV encephalitis. J Neuroimmunol 120: 94–102.
  11. 11. Bafica A, Scanga CA, Serhan C, Machado F, White S, et al. (2005) Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J Clin Invest 115: 1601–1606.
  12. 12. Pavanelli WR, Gutierrez FR, Mariano FS, Prado CM, Ferreira BR, et al. (2010) 5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. Microbes Infect 12: 587–597.
  13. 13. Medeiros AI, Silva CL, Malheiro A, Maffei CM, Faccioli LH (1999) Leukotrienes are involved in leukocyte recruitment induced by live Histoplasma capsulatum or by the beta-glucan present in their cell wall. Br J Pharmacol 128: 1529–1537.
  14. 14. Mancuso P, Standiford TJ, Marshall T, Peters-Golden M (1998) 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect Immun 66: 5140–5146.
  15. 15. Serezani CH, Aronoff DM, Jancar S, Mancuso P, Peters-Golden M (2005) Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood 106: 1067–1075.
  16. 16. Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD, et al. (2003) Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4: 982–990.
  17. 17. Goodarzi K, Goodarzi M, Tager AM, Luster AD, von Andrian UH (2003) Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol 4: 965–973.
  18. 18. Costa MF, de Souza-Martins R, de Souza MC, Benjamim CF, Piva B, et al. (2010) Leukotriene B4 mediates gammadelta T lymphocyte migration in response to diverse stimuli. J Leukoc Biol 87: 323–332.
  19. 19. Peters-Golden M, Henderson WR Jr (2007) Leukotrienes. N Engl J Med 357: 1841–1854.
  20. 20. Medeiros AI, Sa-Nunes A, Turato WM, Secatto A, Frantz FG, et al. (2008) Leukotrienes are potent adjuvant during fungal infection: effects on memory T cells. J Immunol 181: 8544–8551.
  21. 21. Brummer E, Stevens DA (1995) Antifungal mechanisms of activated murine bronchoalveolar or peritoneal macrophages for Histoplasma capsulatum. Clin Exp Immunol 102: 65–70.
  22. 22. Serezani CH, Perrela JH, Russo M, Peters-Golden M, Jancar S (2006) Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility. J Immunol 177: 3201–3208.
  23. 23. Serezani CH, Lewis C, Jancar S, Peters-Golden M (2011) Leukotriene B4 amplifies NF-kappaB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression. J Clin Invest 121: 671–682.
  24. 24. Talvani A, Machado FS, Santana GC, Klein A, Barcelos L, et al. (2002) Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect Immun 70: 4247–4253.
  25. 25. Huffman LJ, Prugh DJ, Millecchia L, Schuller KC, Cantrell S, et al. (2003) Nitric oxide production by rat bronchoalveolar macrophages or polymorphonuclear leukocytes following intratracheal instillation of lipopolysaccharide or silica. J Biosci 28: 29–37.
  26. 26. Schwab JM, Serhan CN (2006) Lipoxins and new lipid mediators in the resolution of inflammation. Curr Opin Pharmacol 6: 414–420.
  27. 27. Clish CB, O'Brien JA, Gronert K, Stahl GL, Petasis NA, et al. (1999) Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc Natl Acad Sci U S A 96: 8247–8252.
  28. 28. Kobayashi Y (2008) The role of chemokines in neutrophil biology. Front Biosci 13: 2400–2407.
  29. 29. Brummer E, Kurita N, Yosihida S, Nishimura K, Miyaji M (1991) Fungistatic activity of human neutrophils against Histoplasma capsulatum: correlation with phagocytosis. J Infect Dis 164: 158–162.
  30. 30. Kurita N, Terao K, Brummer E, Ito E, Nishimura K, et al. (1991) Resistance of Histoplasma capsulatum to killing by human neutrophils. Evasion of oxidative burst and lysosomal-fusion products. Mycopathologia 115: 207–213.
  31. 31. Newman SL, Gootee L, Gabay JE (1993) Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules. J Clin Invest 92: 624–631.
  32. 32. Mancuso P, Nana-Sinkam P, Peters-Golden M (2001) Leukotriene B4 augments neutrophil phagocytosis of Klebsiella pneumoniae. Infect Immun 69: 2011–2016.
  33. 33. Peters-Golden M, Coffey M (1998) Role of leukotrienes in antimicrobial defense of the lung. J Lab Clin Med 132: 251–257.
  34. 34. Mancuso P, Peters-Golden M (2000) Modulation of alveolar macrophage phagocytosis by leukotrienes is Fc receptor-mediated and protein kinase C-dependent. Am J Respir Cell Mol Biol 23: 727–733.
  35. 35. Morato-Marques M, Campos MR, Kane S, Rangel AP, Lewis C, et al. (2011) Leukotrienes target F-actin/cofilin-1 to enhance alveolar macrophage anti-fungal activity. J Biol Chem 286: 28902–28913.
  36. 36. Newman SL (1999) Macrophages in host defense against Histoplasma capsulatum. Trends Microbiol 7: 67–71.
  37. 37. Islam SA, Thomas SY, Hess C, Medoff BD, Means TK, et al. (2006) The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans. Blood 107: 444–453.
  38. 38. Canetti C, Hu B, Curtis JL, Peters-Golden M (2003) Syk activation is a leukotriene B4-regulated event involved in macrophage phagocytosis of IgG-coated targets but not apoptotic cells. Blood 102: 1877–1883.
  39. 39. Sa-Nunes A, Medeiros AI, Nicolete R, Frantz FG, Panunto-Castelo A, et al. (2005) Efficacy of cell-free antigens in evaluating cell immunity and inducing protection in a murine model of histoplasmosis. Microbes Infect 7: 584–592.
  40. 40. Aronoff DM, Canetti C, Peters-Golden M (2004) Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J Immunol 173: 559–565.
  41. 41. Carlos D, Fremond C, Samarina A, Vasseur V, Maillet I, et al. (2009) Histamine plays an essential regulatory role in lung inflammation and protective immunity in the acute phase of Mycobacterium tuberculosis infection. Infect Immun 77: 5359–5368.
  42. 42. Faccioli LH, Souza GE, Cunha FQ, Poole S, Ferreira SH (1990) Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration “in vivo” by indirect mechanisms. Agents Actions 30: 344–349.